Cargando…

Prevalence of HIV and HCV among injecting drug users in three selected WHO-EMRO countries: a meta-analysis

BACKGROUND: HIV and Hepatitis C Virus (HCV) infections are responsible for a significant burden of mortality and morbidity, particularly in developing countries. This study sought to determine the prevalence of HIV and Hepatitis C among injecting drug users in Afghanistan, Iran, and Pakistan. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shayan, Shah Jahan, Nazari, Rajab, Kiwanuka, Frank
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161998/ https://www.ncbi.nlm.nih.gov/pubmed/34044849 http://dx.doi.org/10.1186/s12954-021-00505-4

Ejemplares similares

Systematic review of the rotavirus infection burden in the WHO-EMRO region
por: Badur, Selim, et al.
Publicado: (2019)

Prevalence of Hepatitis C Virus Genotypes Among Patients in Countries of the Eastern Mediterranean Regional Office of WHO (EMRO): A Systematic Review and Meta-Analysis
por: Sadeghi, Farzin, et al.
Publicado: (2016)

Towards Improving Hospital Managers’ Performance in Iran: History of a Pioneer Program Among EMRO Countries
por: Maher, Ali, et al.
Publicado: (2019)

Economic Burden of Injuries argues for more Safe Communities in Iran and EMRO
por: Dalal, Koustuv
Publicado: (2019)

Hepatitis C virus (HCV) infection and re-infection among HCV- and HIV/HCV-infected injection drug users
por: Conway, B, et al.
Publicado: (2010)

Relative Importance of Hepatitis B and C Viruses in Hepatocellular Carcinoma in EMRO Countries and the Middle East: A Systematic Review
por: Alavian, Seyed Moayed, et al.
Publicado: (2016)

Molecular Epidemiology of HCV Monoinfection and HIV/HCV Coinfection in Injection Drug Users in Liuzhou, Southern China
por: Tan, Yi, et al.
Publicado: (2008)

Family history of cancer as a potential risk factor for colorectal cancer in EMRO countries: a systematic review and meta-analysis
por: Keivanlou, Mohammad-Hossein, et al.
Publicado: (2023)

Barriers to patient and family‐centred care in adult intensive care units: A systematic review
por: Kiwanuka, Frank, et al.
Publicado: (2019)

Developing an appropriate model for self-care of hypertensive patients: first experience from EMRO
por: Sadeghi, Masoumeh, et al.
Publicado: (2013)

HCV monoinfection and HIV/HCV coinfection enhance T-cell immune senescence in injecting drug users early during infection
por: Grady, Bart P. X., et al.
Publicado: (2016)

Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review
por: Degenhardt, Louisa, et al.
Publicado: (2017)

Lack of Knowledge About Hepatitis C Infection Rates Among Patients With Inherited Coagulation Disorders in Countries Under the Eastern Mediterranean Region Office of WHO (EMRO): A Meta-Analysis
por: Alavian, Seyed Moayed, et al.
Publicado: (2012)

Frequency of HBV, HCV and HIV infections among hospitalized injecting drug users in Kashan
por: Sharif, M., et al.
Publicado: (2009)

HCV and HIV co-infection among people who inject drugs in Vietnam
por: THINH, Vu Toan, et al.
Publicado: (2020)

Selecting the Appropriate Method of Training Family Physicians in Iran to Achieve EMRO-Declared Perspective by 2030
por: Aghdak, Pejman, et al.
Publicado: (2021)

HCV prevalence can predict HIV epidemic potential among people who inject drugs: mathematical modeling analysis
por: Akbarzadeh, Vajiheh, et al.
Publicado: (2016)

HCV/HIV coinfection among people who inject drugs and enter opioid substitution treatment in Greece: prevalence and correlates
por: Fotiou, Anastasios, et al.
Publicado: (2016)

Detection of HCV-Specific IFN-γ Responses in HCV Antibody and HCV RNA Negative Injecting Drug Users
por: Flynn, Jacqueline K, et al.
Publicado: (2014)

Cost Effectiveness of Screening Strategies for Early Identification of HIV and HCV Infection in Injection Drug Users
por: Cipriano, Lauren E., et al.
Publicado: (2012)

Epidemic dispersion of HIV and HCV in a population of co-infected Romanian injecting drug users
por: Paraschiv, Simona, et al.
Publicado: (2017)

Prevalences and associated risk factors of HCV/HIV co-infection and HCV mono-infection among injecting drug users in a methadone maintenance treatment program in Taipei, Taiwan
por: Yen, Yung-Feng, et al.
Publicado: (2012)

The impact of HCV therapy in a high HIV-HCV prevalence population: A modeling study on people who inject drugs in Ho Chi Minh City, Vietnam
por: Birger, Ruthie B., et al.
Publicado: (2017)

High Prevalence of HIV, HCV, HBV and Co-Infection and Associated Risk Factors among Injecting Drug Users in Yunnan Province, China
por: Zhou, Yan-Heng, et al.
Publicado: (2012)

Prevalence of HIV among injection drug users in Georgia
por: Chikovani, Ivdity, et al.
Publicado: (2011)

High HCV seroprevalence and HIV drug use risk behaviors among injection drug users in Pakistan
por: Kuo, Irene, et al.
Publicado: (2006)

HIV/HCV co-infection and associated risk factors among injecting drug users in Dar es Salaam, Tanzania: potential for HCV elimination
por: Leyna, Germana Henry, et al.
Publicado: (2019)

Modelling the spatial distribution of five natural hazards in the context of the WHO/EMRO Atlas of Disaster Risk as a step towards the reduction of the health impact related to disasters
por: El Morjani, Zine El Abidine, et al.
Publicado: (2007)

Control over Drug Acquisition, Preparation, and Injection: Implications for HIV and HCV Risk among Young Female Injection Drug Users
por: Wagner, Karla D., et al.
Publicado: (2013)

Diverse HCV Strains And HIV URFS Identified Amongst People Who Inject Drugs In India
por: Rodgers, Mary A., et al.
Publicado: (2020)

Social determinants and risk behaviors associated with prevalent Hepatitis C and HIV/HCV co-infection among male injection drug users in Nepal
por: Kakchapati, Sampurna, et al.
Publicado: (2017)

Comparison of the Efficacies of Direct-Acting Antiviral Treatment for HCV Infection in People Who Inject Drugs and Non-Drug Users
por: Hsu, Jui-Ting, et al.
Publicado: (2022)

Univariable associations between a history of incarceration and HIV and HCV prevalence among people who inject drugs across 17 countries in Europe 2006 to 2020 – is the precautionary principle applicable?
por: Wiessing, Lucas, et al.
Publicado: (2021)

Prevalence of HIV, Hepatitis B and C Infections and an Assessment of HCV-Genotypes and Two IL28B SNPs among People Who Inject Drugs in Three Regions of Nepal
por: Kinkel, Hans-Tilmann, et al.
Publicado: (2015)

Consistency of spatial dynamics of HIV-1 and HCV among HIV-1/HCV coinfected drug users in China
por: Wang, Yu, et al.
Publicado: (2021)

Prevalence of HCV among people who inject drugs in Brussels—a respondent-driven sampling survey
por: Van Baelen, Luk, et al.
Publicado: (2020)

HCV incidence is associated with injecting partner age and HCV serostatus mixing in young adults who inject drugs in San Francisco
por: Page, Kimberly, et al.
Publicado: (2019)

Incidence of HIV and HCV in people who inject drugs: a systematic and meta-analysis review protocol
por: Sharhani, Asaad, et al.
Publicado: (2021)

Gender Differences in HIV, HCV risk and Prevention Needs Among People who Inject drug in Vietnam
por: Giang, Hoang Thi, et al.
Publicado: (2022)

Baseline prevalence and correlates of HIV and HCV infection among people who inject drugs accessing a syringe services program; Miami, FL
por: Bartholomew, Tyler S., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_82shn477pvaqae6ui0migjf4gq